Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2025-12-24 @ 7:13 PM
NCT ID:
NCT06470503
Eligibility Criteria:
Inclusion Criteria:
* Age 18 or older.
* KPS ≥70
* Histologically confirmed cancer and radiologically documented NSBM metastases. Spine metastases are allowed if they do not meet the exclusion criteria below.
* At least one painful NSBM treated with palliative radiotherapy.
* Independent with ambulation and transfers. Ambulatory aids are permitted.
* Life expectancy of at least 6 months
Exclusion Criteria:
* Any untreated metastatic disease that may preclude safely performing physical exercise including:
* History of leptomeningeal disease
* Active (untreated/progressive) malignant spinal cord or cauda equina compression
* Bilsky 2 or 3
* Neurological compromise secondary to CNS involvement
* Symptomatic brain metastases prohibiting exercise due to neurological compromise
* High risk of instability of any boney lesion(s) that may require orthopedic intervention
* SINS score \> 7
* Mirels score \> 6
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06470503
Study Brief:
Protocol Section:
NCT06470503